Wanlu Duan

579 total citations
10 papers, 462 citations indexed

About

Wanlu Duan is a scholar working on Epidemiology, Immunology and Biomedical Engineering. According to data from OpenAlex, Wanlu Duan has authored 10 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 4 papers in Immunology and 4 papers in Biomedical Engineering. Recurrent topics in Wanlu Duan's work include Nanoplatforms for cancer theranostics (4 papers), Nanoparticle-Based Drug Delivery (3 papers) and Hepatitis B Virus Studies (3 papers). Wanlu Duan is often cited by papers focused on Nanoplatforms for cancer theranostics (4 papers), Nanoparticle-Based Drug Delivery (3 papers) and Hepatitis B Virus Studies (3 papers). Wanlu Duan collaborates with scholars based in China and Ethiopia. Wanlu Duan's co-authors include Fei Yan, Hao Wu, Hongmei Liu, Xin Liu, Zhiting Deng, Hairong Zheng, Hong Liu, Hairong Zheng, Min Pan and Yuli Zhou and has published in prestigious journals such as Radiology, Journal of Controlled Release and Theranostics.

In The Last Decade

Wanlu Duan

10 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wanlu Duan China 6 369 196 145 100 95 10 462
Mukaddes Izci Belgium 4 252 0.7× 185 0.9× 131 0.9× 54 0.5× 84 0.9× 7 393
Christy Maksoudian Belgium 8 299 0.8× 223 1.1× 172 1.2× 61 0.6× 126 1.3× 13 511
Kozo Miyazaki Japan 11 300 0.8× 191 1.0× 144 1.0× 137 1.4× 171 1.8× 14 629
Astrid Bjørkøy Norway 11 307 0.8× 206 1.1× 159 1.1× 52 0.5× 129 1.4× 26 544
Yuzhu Yao China 11 344 0.9× 98 0.5× 142 1.0× 71 0.7× 189 2.0× 13 500
Xuewei Qu United States 8 245 0.7× 126 0.6× 150 1.0× 46 0.5× 100 1.1× 13 427
Vertika Pathak Germany 8 429 1.2× 310 1.6× 158 1.1× 43 0.4× 121 1.3× 8 628
Hohyeon Lee South Korea 13 433 1.2× 149 0.8× 188 1.3× 82 0.8× 127 1.3× 23 631
Jianli Ren China 15 501 1.4× 193 1.0× 171 1.2× 69 0.7× 117 1.2× 25 667
Hengjing Yi China 7 508 1.4× 135 0.7× 120 0.8× 140 1.4× 138 1.5× 8 557

Countries citing papers authored by Wanlu Duan

Since Specialization
Citations

This map shows the geographic impact of Wanlu Duan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanlu Duan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanlu Duan more than expected).

Fields of papers citing papers by Wanlu Duan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanlu Duan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanlu Duan. The network helps show where Wanlu Duan may publish in the future.

Co-authorship network of co-authors of Wanlu Duan

This figure shows the co-authorship network connecting the top 25 collaborators of Wanlu Duan. A scholar is included among the top collaborators of Wanlu Duan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanlu Duan. Wanlu Duan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Liu, Qian, Wanlu Duan, Zhi Duan, et al.. (2025). Intrahepatic CD161hiCD8+T Cell Recruitment Has a Pathogenetic Potential in Chronic HBV Infection. Immunity Inflammation and Disease. 13(1). e70118–e70118. 1 indexed citations
2.
Duan, Wanlu, et al.. (2024). Characteristics of Virology and Immune Inflammation of Epstein-Barr Virus Infection Related Non-Neoplastic Diseases in Children. Clinical Laboratory. 70(05/2024). 2 indexed citations
3.
Li, Jianfei, Zhi Duan, Futing Liu, et al.. (2024). Interferon-induced polarization of M1 macrophages mediates antiviral activity against the hepatitis B virus via the hepcidin-ferroportin axis. International Immunopharmacology. 134. 112219–112219. 3 indexed citations
4.
Zhang, Hao, Futing Liu, Jianfei Li, et al.. (2024). Activation of the cGAS-STING pathway by viral dsDNA leading to M1 polarization of macrophages mediates antiviral activity against hepatitis B virus. Immunobiology. 229(3). 152810–152810. 7 indexed citations
5.
Zhang, Hao, Teng Liang, Wanlu Duan, et al.. (2024). STING modulates HBV-related acute-on-chronic liver failure by mediating autophagy and macrophage polarization. Immunobiology. 230(1). 152860–152860. 1 indexed citations
6.
Zhang, Yunyun, Hao Zhang, Zhi Duan, et al.. (2023). Characteristics of immunological events in Epstein-Barr virus infection in children with infectious mononucleosis. Frontiers in Pediatrics. 11. 1060053–1060053. 10 indexed citations
7.
Yan, Fei, Song Wang, Wei Yang, et al.. (2017). Tumor-penetrating Peptide-integrated Thermally Sensitive Liposomal Doxorubicin Enhances Efficacy of Radiofrequency Ablation in Liver Tumors. Radiology. 285(2). 462–471. 16 indexed citations
8.
Yan, Fei, Wanlu Duan, Hao Wu, et al.. (2016). NIR-Laser-Controlled Drug Release from DOX/IR-780-Loaded Temperature-Sensitive-Liposomes for Chemo-Photothermal Synergistic Tumor Therapy. Theranostics. 6(13). 2337–2351. 136 indexed citations
9.
Deng, Zhiting, Yang Xiao, Min Pan, et al.. (2016). Hyperthermia-triggered drug delivery from iRGD-modified temperature-sensitive liposomes enhances the anti-tumor efficacy using high intensity focused ultrasound. Journal of Controlled Release. 243. 333–341. 72 indexed citations
10.
Yan, Fei, Hao Wu, Hongmei Liu, et al.. (2015). Molecular imaging-guided photothermal/photodynamic therapy against tumor by iRGD-modified indocyanine green nanoparticles. Journal of Controlled Release. 224. 217–228. 214 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026